Methods: Qualitative results were evaluated using sensitivity and specificity. Quantitative results were evaluated using z-scores and the standard deviation of Horwitz.
Introduction
The use of oral fluid as a matrix for detection of drugs of abuse has increased continuously over the last ten years. [1] More and more information has become available on the pharmacokinetics of both licit and illicit drugs [2] , leading to a better understanding of the relationship between concentrations found in oral fluid and the effects of the drugs. Because of its non-invasive, supervised and easy collection, policy makers are also interested in oral fluid as an alternative matrix to blood and urine for detection of impaired drivers. Several countries worldwide (Australia, France, Belgium) have already implemented legislation based on oral fluid.
DRUID (Driving Under the Influence of Drugs, Alcohol and Medicines) is an integrated research
project funded by the European Commission that deals with licit and illicit drugs in driving. Oral fluid is collected in this study for several purposes: it is taken from randomly selected drivers in order to calculate the prevalence of psychoactive substances in the general European driving population and to calculate odds ratios to be injured in an accident after taking these substances. Also, all experimental studies in DRUID are collecting oral fluid for comparison with concentrations in other matrices. Finally, oral fluid is taken as reference samples from patients in pain clinics, coffeeshops and centers for treatment of drug addiction to test rapid on-site testing devices for screening of drugs of abuse in oral fluid.
In total over 40,000 samples will be collected using the Statsure saliva sampler™ (Statsure Diagnostic Systems, Framingham, MA, USA). This collection device was chosen from ten devices based on ease of collection, stability and recovery of analytes and collection volume. [3] All samples have to be analyzed for the presence of a 'core list' of 22 substances containing both licit and illicit drugs.
Minimum analytical cut-offs were defined for all analytes. [4] (Table 1) Samples are analyzed by eleven countries across Europe. Since results of the different laboratories will be combined for calculations and most labs had to develop new methods for this project, interlaboratory quality control (i.e. proficiency testing) is necessary. The aim of the proficiency-testing scheme was to ensure that the quality and comparability of the results from all laboratories. In the past, similar programs have been organized: UKNEQAS (United Kingdom National External Quality Assessment Scheme) was the first to publish interlaboratory results [5] , followed by ORALVEQ [6, 7] and the ROSITA-2 project. [8] None of these existing programs could however be used for the DRUID project since tests had to be adapted to the DRUID core list of analytes and cut-offs. Laboratories were instructed to add 1 mL of the neat oral fluid sample to a StatSure collection device.
Materials and methods

Drug
The 1 mL of neat PT oral fluid was added directly to the buffer in the collection tube. The neat oral fluid was not to be added to the swab pad nor was the swab pad to be added to the buffer in the collection tube. Analytes were screened, identified and quantified using a mass spectroscopy-based technique. Reported analyte concentrations were corrected for dilutions to provide the concentration for the neat oral fluid shipped to the laboratory. Samples were expected to be tested and electronically reported to RTI within 10 working days after receipt. Results were reported back to each participating lab anonymously, but with identification to the DRUID coordinator to allow the latter to make corrective actions.
Qualitative results were evaluated using sensitivity and specificity. Sensitivity is defined as the number of analytes correctly reported positive divided by the total number of analytes spiked in the samples.
Specificity is defined as the number of analytes correctly reported negative divided by the total number of core list analytes not spiked in the samples.
Quantification was evaluated using the standard deviation according to Horwitz (SD HOR ). This parameter is used in the IUPAC international Harmonized Protocol for proficiency testing and is independent of the results of the laboratories as a group. Z-scores were calculated using SD HOR :
Results
Eight laboratories reported results in the first round, three laboratories did not yet report because method development and validation were still being performed. In the second to fourth round, all eleven laboratories reported results. Not all laboratories reported results for ethanol, since in some countries ethanol concentration for each volunteer was already known based on breathalyzer results from standard police procedure and hence analysis was not mandatory.
Nine laboratories performed the analysis using LC-MS/MS (liquid chromatography tandem mass spectrometry), two laboratories used GC-MS (gas chromatography mass spectrometry). Ethanol analyses were performed with either headspace gas chromatography or enzymatic methods.
Average coefficients of variation (CV) were below 20% for 4 out of 22 analytes, 13 others had an average CV between 20 and 30%. Specificity was above 99% for all analytes; sensitivity varied between 81.7 and 100%, 20 out of 22 analytes had sensitivity above 90%. (Table 1 ).
In Figure 1 , it can be seen that quantification improved over the rounds as well: laboratories with a satisfactory z-score (absolute value lower than 2) increased from 79.4% over 86.8% and 88.7% to 89.2%. Z-scores were also combined for the following groups: opiates (including methadone), In testing rounds 1 and 4, several labs reported benzoylecgonine present in samples where only cocaine was spiked but no benzoylecgonine. After consultation with participating laboratories this problem could be explained by hydrolysis of cocaine during extraction and low extraction yields for benzoylecgonine or by pre-analytical hydrolysis, either in sample preparation at the manufacture or during shipment. Since the exact source of the benzoylecgonine could not be pointed out, and the presence of variable amounts of benzoylecgonine is to be expected in samples containing cocaine, these reported values were not scored as false positives.
Discussion
Prior to the DRUID project, most participating laboratories did not analyze oral fluid on a routine basis and therefore had to develop LC-MS/MS or GC-MS methods specifically for this project. In the first round of proficiency testing, most laboratories were therefore still in the process of development and validation or had only recently completed this, explaining the lower scores in the first rounds. After each round, results were discussed in meetings with the participating laboratories and the DRUID coordinator (based on Z-scores), problems were identified and solutions sought for. Thanks to this extensive distribution of knowledge between the participating laboratories, the quality of analyses increased significantly over time, leading to a last round with low false negative (0.9%) and false positive (0.4%) results. Satisfactory quantification was achieved in almost 90% of cases.
Zopiclone remained the most difficult compound for qualitative analysis. It is known that cyclopyrrolones can hydrolyse under different conditions to 2-amino-5-chloropyridine, which could explain the analytical problems. [9, 10] Moreover, when the participating laboratories developed their confirmation methods, deuterated zopiclone was not yet available to be used as internal standard.
Amphetamines proved to be the most difficult class of drugs for quantitative analyses.
Laboratories were not allowed to analyze specimens until approval from the coordinator was obtained, which was based on internal validation and proficiency testing results. This was decided in order to further improve quality of analysis of specimens from DRUID volunteers.
Analysis using coefficients of variation shows that the DRUID laboratories have a lower variance in results than the participants of previously published proficiency testing programs for the majority of analytes: in this program the average CV was lower than 30% for 77.3% of analytes, while this was the case for only 46.1 % of analytes in UKNEQAS and none of the analytes in ORALVEQ. [5, 6] It should be noted that two key variables in oral fluid analysis are not considered in the program:
sample volume and recovery from the device. However for analysis of all real samples, variation is minimized since weighing of the sample volume is mandatory and recovery from the device is reproducible because of the use of the same collection and extraction device. 
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